SIMILAR PATTERNS OF AMINO ACIDS FOR 2A7Q_A_CFBA328

List of similar pattern of amino acids derived from ASSAM search

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click link on the last column to view superposed patterns of amino acids in NGL viewer)
(Note that only 3-12 residue patterns can be used for ASSAM searches)
Filter list by:
Hit Macromolecule/
Organism		 Pfam Res. Interface HETATM RMSD Dali Z-score Seq. Identity (%) View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1hcu ALPHA-1,2-MANNOSIDAS
E

(Trichoderma
reesei) 		PF01532
(Glyco_hydro_47) 		5 GLU A 486
TYR A 250
ARG A 104
PHE A  99
GLU A 249
 None
None
None
None
CA  A1495 ( 4.2A)
 1.49A 2a7qA-1hcuA:
0.0		 2a7qA-1hcuA:
18.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1p75 THYMIDINE KINASE

(Equid
alphaherpesvirus
4) 		PF00693
(Herpes_TK) 		5 GLU A  60
TRP A  65
GLN A 102
ARG A 139
PHE A 148
 T5A  A 501 (-2.5A)
None
T5A  A 501 (-3.1A)
T5A  A 501 (-3.7A)
T5A  A 501 (-3.5A)
 1.22A 2a7qA-1p75A:
15.5		 2a7qA-1p75A:
23.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1vtk THYMIDINE KINASE

(Human
alphaherpesvirus
1) 		PF00693
(Herpes_TK) 		5 GLU A  83
TRP A  88
TYR A 101
GLN A 125
GLU A 225
 TMP  A 500 (-2.7A)
None
TMP  A 500 (-4.5A)
TMP  A 500 (-3.0A)
TMP  A 500 (-3.5A)
 1.13A 2a7qA-1vtkA:
16.6		 2a7qA-1vtkA:
20.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1vtk THYMIDINE KINASE

(Human
alphaherpesvirus
1) 		PF00693
(Herpes_TK) 		5 GLU A  83
TYR A 101
GLN A 125
ARG A 163
GLU A 225
 TMP  A 500 (-2.7A)
TMP  A 500 (-4.5A)
TMP  A 500 (-3.0A)
TMP  A 500 (-3.3A)
TMP  A 500 (-3.5A)
 1.20A 2a7qA-1vtkA:
16.6		 2a7qA-1vtkA:
20.68
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2a30 DEOXYCYTIDINE KINASE

(Homo sapiens) 		PF01712
(dNK) 		12 GLU A  53
VAL A  55
TRP A  58
MET A  85
TYR A  86
PHE A  96
GLN A  97
ARG A 104
ARG A 128
PHE A 137
GLU A 197
TYR A 204
 DCZ  A 302 (-3.0A)
None
None
DCZ  A 302 ( 4.3A)
DCZ  A 302 (-4.6A)
DCZ  A 302 (-4.6A)
DCZ  A 302 (-3.2A)
None
DCZ  A 302 (-4.1A)
DCZ  A 302 (-3.8A)
DCZ  A 302 (-3.5A)
None
 0.71A 2a7qA-2a30A:
36.6		 2a7qA-2a30A:
94.30
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2a30 DEOXYCYTIDINE KINASE

(Homo sapiens) 		PF01712
(dNK) 		5 VAL A  55
PHE A  96
GLN A  97
ARG A 128
GLU A 196
 None
DCZ  A 302 (-4.6A)
DCZ  A 302 (-3.2A)
DCZ  A 302 (-4.1A)
None
 1.33A 2a7qA-2a30A:
36.6		 2a7qA-2a30A:
94.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2jaq DEOXYGUANOSINE
KINASE

(Mycoplasma
mycoides) 		PF01712
(dNK) 		8 VAL A  33
TYR A  43
GLN A  54
ARG A  61
ARG A  78
PHE A  86
GLU A 150
TYR A 157
 DCP  A1202 (-4.6A)
None
DCP  A1202 (-2.9A)
None
DCP  A1202 (-2.8A)
DCP  A1202 (-3.6A)
DCP  A1202 (-3.5A)
None
 0.84A 2a7qA-2jaqA:
22.6		 2a7qA-2jaqA:
27.04
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2jcs DEOXYNUCLEOSIDE
KINASE

(Drosophila
melanogaster) 		PF01712
(dNK) 		8 VAL A  54
TRP A  57
MET A  69
PHE A  80
GLN A  81
ARG A 105
PHE A 114
TYR A 179
 TTP  A1210 (-4.5A)
None
TTP  A1210 (-4.8A)
TTP  A1210 (-4.2A)
TTP  A1210 (-3.0A)
TTP  A1210 (-3.7A)
TTP  A1210 (-3.5A)
None
 0.87A 2a7qA-2jcsA:
26.2		 2a7qA-2jcsA:
31.32
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2jcs DEOXYNUCLEOSIDE
KINASE

(Drosophila
melanogaster) 		PF01712
(dNK) 		9 VAL A  54
TRP A  57
MET A  69
TYR A  70
PHE A  80
GLN A  81
PHE A 114
GLU A 172
TYR A 179
 TTP  A1210 (-4.5A)
None
TTP  A1210 (-4.8A)
TTP  A1210 (-4.6A)
TTP  A1210 (-4.2A)
TTP  A1210 (-3.0A)
TTP  A1210 (-3.5A)
TTP  A1210 (-3.6A)
None
 0.69A 2a7qA-2jcsA:
26.2		 2a7qA-2jcsA:
31.32
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2jcs DEOXYNUCLEOSIDE
KINASE

(Drosophila
melanogaster) 		PF01712
(dNK) 		5 VAL A  54
TRP A  57
PHE A  80
GLN A  81
GLU A 171
 TTP  A1210 (-4.5A)
None
TTP  A1210 (-4.2A)
TTP  A1210 (-3.0A)
None
 1.33A 2a7qA-2jcsA:
26.2		 2a7qA-2jcsA:
31.32
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2ocp DEOXYGUANOSINE
KINASE

(Homo sapiens) 		PF01712
(dNK) 		6 GLU A  70
VAL A  72
TRP A  75
MET A  99
PHE A 110
GLN A 111
 None
DTP  A 301 (-4.1A)
None
DTP  A 301 ( 3.9A)
DTP  A 301 (-4.2A)
DTP  A 301 (-2.9A)
 1.06A 2a7qA-2ocpA:
33.0		 2a7qA-2ocpA:
46.62
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2ocp DEOXYGUANOSINE
KINASE

(Homo sapiens) 		PF01712
(dNK) 		10 VAL A  72
TRP A  75
MET A  99
TYR A 100
PHE A 110
GLN A 111
ARG A 142
PHE A 151
GLU A 211
TYR A 218
 DTP  A 301 (-4.1A)
None
DTP  A 301 ( 3.9A)
DTP  A 301 (-4.5A)
DTP  A 301 (-4.2A)
DTP  A 301 (-2.9A)
DTP  A 301 (-3.2A)
DTP  A 301 (-3.3A)
DTP  A 301 (-3.5A)
None
 0.55A 2a7qA-2ocpA:
33.0		 2a7qA-2ocpA:
46.62
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2ocp DEOXYGUANOSINE
KINASE

(Homo sapiens) 		PF01712
(dNK) 		9 VAL A  72
TRP A  75
TYR A 100
PHE A 110
ARG A 118
ARG A 142
PHE A 151
GLU A 211
TYR A 218
 DTP  A 301 (-4.1A)
None
DTP  A 301 (-4.5A)
DTP  A 301 (-4.2A)
DTP  A 301 (-3.1A)
DTP  A 301 (-3.2A)
DTP  A 301 (-3.3A)
DTP  A 301 (-3.5A)
None
 0.81A 2a7qA-2ocpA:
33.0		 2a7qA-2ocpA:
46.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5y3t E3 UBIQUITIN-PROTEIN
LIGASE RNF31
RANBP-TYPE AND
C3HC4-TYPE ZINC
FINGER-CONTAINING
PROTEIN 1
SHARPIN

(Mus musculus) 		no annotation 5 GLU B 561
GLN B 507
ARG B 555
GLU A  10
TYR C 283
 None
 1.48A 2a7qA-5y3tB:
undetectable		 2a7qA-5y3tB:
15.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6g2j NADH DEHYDROGENASE
[UBIQUINONE] 1 ALPHA
SUBCOMPLEX SUBUNIT
10, MITOCHONDRIAL

(Mus musculus) 		no annotation 5 GLU O  53
TYR O  83
ARG O 126
PHE O 134
TYR O 198
 ADP  O 401 ( 4.7A)
ADP  O 401 (-4.9A)
ADP  O 401 ( 4.3A)
ADP  O 401 (-3.6A)
None
 0.79A 2a7qA-6g2jO:
undetectable		 2a7qA-6g2jO:
14.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6g2j NADH DEHYDROGENASE
[UBIQUINONE] 1 ALPHA
SUBCOMPLEX SUBUNIT
10, MITOCHONDRIAL

(Mus musculus) 		no annotation 5 GLU O  53
TYR O  83
GLN O  97
PHE O 134
TYR O 198
 ADP  O 401 ( 4.7A)
ADP  O 401 (-4.9A)
ADP  O 401 (-3.5A)
ADP  O 401 (-3.6A)
None
 1.06A 2a7qA-6g2jO:
undetectable		 2a7qA-6g2jO:
14.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6g2j NADH DEHYDROGENASE
[UBIQUINONE] 1 ALPHA
SUBCOMPLEX SUBUNIT
10, MITOCHONDRIAL

(Mus musculus) 		no annotation 5 TYR O  83
ARG O 126
PHE O 134
GLU O 191
TYR O 198
 ADP  O 401 (-4.9A)
ADP  O 401 ( 4.3A)
ADP  O 401 (-3.6A)
ADP  O 401 (-3.2A)
None
 0.77A 2a7qA-6g2jO:
undetectable		 2a7qA-6g2jO:
14.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6g2j NADH DEHYDROGENASE
[UBIQUINONE] 1 ALPHA
SUBCOMPLEX SUBUNIT
10, MITOCHONDRIAL

(Mus musculus) 		no annotation 5 TYR O  83
GLN O  97
PHE O 134
GLU O 191
TYR O 198
 ADP  O 401 (-4.9A)
ADP  O 401 (-3.5A)
ADP  O 401 (-3.6A)
ADP  O 401 (-3.2A)
None
 0.92A 2a7qA-6g2jO:
undetectable		 2a7qA-6g2jO:
14.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1c9k ADENOSYLCOBINAMIDE
KINASE

(Salmonella
enterica) 		PF02283
(CobU) 		4 ILE A  67
ASP A 166
LEU A 161
ARG A 124
 None
 1.47A 2a7qA-1c9kA:
0.7		 2a7qA-1c9kA:
20.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1e4o MALTODEXTRIN
PHOSPHORYLASE

(Escherichia
coli) 		PF00343
(Phosphorylase) 		4 ILE A  70
ASP A 159
LEU A 255
ARG A 455
 None
 1.33A 2a7qA-1e4oA:
2.5		 2a7qA-1e4oA:
15.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1gnx BETA-GLUCOSIDASE

(Streptomyces
sp.) 		PF00232
(Glyco_hydro_1) 		4 ILE A 459
ASP A  76
LEU A  83
ARG A 445
 None
 1.01A 2a7qA-1gnxA:
1.0		 2a7qA-1gnxA:
18.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1kt8 BRANCHED-CHAIN AMINO
ACID
AMINOTRANSFERASE,
MITOCHONDRIAL

(Homo sapiens) 		PF01063
(Aminotran_4) 		4 ILE A  53
ASP A 130
LEU A 140
ARG A 123
 None
 1.23A 2a7qA-1kt8A:
undetectable		 2a7qA-1kt8A:
20.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1oyz HYPOTHETICAL PROTEIN
YIBA

(Escherichia
coli) 		PF13646
(HEAT_2) 		4 ILE A 112
ASP A 170
LEU A 163
ARG A 108
 None
 1.16A 2a7qA-1oyzA:
undetectable		 2a7qA-1oyzA:
20.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1qvr CLPB PROTEIN

(Thermus
thermophilus) 		PF00004
(AAA)
PF02861
(Clp_N)
PF07724
(AAA_2)
PF10431
(ClpB_D2-small) 		4 ILE A 715
ASP A 730
LEU A 736
ARG A 755
 None
 1.36A 2a7qA-1qvrA:
1.2		 2a7qA-1qvrA:
15.66
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1t5o TRANSLATION
INITIATION FACTOR
EIF2B, SUBUNIT DELTA

(Archaeoglobus
fulgidus) 		PF01008
(IF-2B) 		4 ILE A  15
ASP A   9
LEU A  12
ARG A 158
 None
 1.24A 2a7qA-1t5oA:
undetectable		 2a7qA-1t5oA:
20.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1uyv ACETYL-COA
CARBOXYLASE

(Saccharomyces
cerevisiae) 		PF01039
(Carboxyl_trans) 		4 ILE A1887
ASP A1825
LEU A1860
ARG A2127
 None
 1.30A 2a7qA-1uyvA:
0.5		 2a7qA-1uyvA:
15.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1vme FLAVOPROTEIN

(Thermotoga
maritima) 		PF00258
(Flavodoxin_1) 		4 ILE A  82
ASP A 161
LEU A 164
ARG A 135
 None
 1.22A 2a7qA-1vmeA:
4.3		 2a7qA-1vmeA:
20.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1ygu LEUKOCYTE COMMON
ANTIGEN

(Homo sapiens) 		PF00102
(Y_phosphatase) 		4 ILE A 612
ASP A 855
LEU A 848
ARG A 619
 None
 1.39A 2a7qA-1yguA:
undetectable		 2a7qA-1yguA:
16.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1zp2 RNA POLYMERASE II
HOLOENZYME
CYCLIN-LIKE SUBUNIT

(Schizosaccharomyces
pombe) 		PF00134
(Cyclin_N) 		4 ILE A 118
ASP A 105
LEU A 109
ARG A 115
 None
 1.44A 2a7qA-1zp2A:
undetectable		 2a7qA-1zp2A:
22.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2a14 INDOLETHYLAMINE
N-METHYLTRANSFERASE

(Homo sapiens) 		PF01234
(NNMT_PNMT_TEMT) 		4 ILE A  68
ASP A  76
LEU A  59
ARG A 132
 None
 1.17A 2a7qA-2a14A:
undetectable		 2a7qA-2a14A:
20.14
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2a30 DEOXYCYTIDINE KINASE

(Homo sapiens) 		PF01712
(dNK) 		4 ILE A  30
ASP A 133
LEU A 141
ARG A 194
 DCZ  A 302 ( 4.3A)
DCZ  A 302 (-3.2A)
None
DCZ  A 302 ( 4.8A)
 0.61A 2a7qA-2a30A:
36.6		 2a7qA-2a30A:
94.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2atf CYSTEINE DIOXYGENASE
TYPE I

(Mus musculus) 		PF05995
(CDO_I) 		4 ILE A  18
ASP A  64
LEU A 154
ARG A  10
 None
 1.44A 2a7qA-2atfA:
undetectable		 2a7qA-2atfA:
21.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2cun PHOSPHOGLYCERATE
KINASE

(Pyrococcus
horikoshii) 		PF00162
(PGK) 		4 ILE A 261
ASP A 203
LEU A 196
ARG A 213
 None
 1.22A 2a7qA-2cunA:
undetectable		 2a7qA-2cunA:
20.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ft3 BIGLYCAN

(Bos taurus) 		PF01462
(LRRNT)
PF13855
(LRR_8) 		4 ILE A 232
ASP A 262
LEU A 266
ARG A 255
 None
 1.03A 2a7qA-2ft3A:
undetectable		 2a7qA-2ft3A:
21.66
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2fuk XC6422 PROTEIN

(Xanthomonas
campestris) 		PF12146
(Hydrolase_4) 		4 ILE A  41
ASP A  95
LEU A  22
ARG A 105
 None
 1.46A 2a7qA-2fukA:
3.5		 2a7qA-2fukA:
20.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2gix INWARD RECTIFIER
POTASSIUM CHANNEL 2

(Mus musculus) 		PF01007
(IRK) 		4 ILE A 248
ASP A 291
LEU A 282
ARG A 235
 None
 1.33A 2a7qA-2gixA:
undetectable		 2a7qA-2gixA:
25.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2j5c 1,8-CINEOLE SYNTHASE

(Salvia
fruticosa) 		PF01397
(Terpene_synth)
PF03936
(Terpene_synth_C) 		4 ILE A 120
ASP A  93
LEU A  99
ARG A 325
 None
None
None
BME  A1592 ( 4.0A)
 1.45A 2a7qA-2j5cA:
undetectable		 2a7qA-2j5cA:
19.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2j7c BETA-GLUCOSIDASE A

(Thermotoga
maritima) 		PF00232
(Glyco_hydro_1) 		4 ILE A 427
ASP A  64
LEU A  71
ARG A 413
 None
 1.03A 2a7qA-2j7cA:
1.4		 2a7qA-2j7cA:
19.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2nvv ACETYL-COA
HYDROLASE/TRANSFERAS
E FAMILY PROTEIN

(Porphyromonas
gingivalis) 		PF02550
(AcetylCoA_hydro)
PF13336
(AcetylCoA_hyd_C) 		4 ILE A 248
ASP A 275
LEU A 270
ARG A 247
 ILE  A 248 ( 0.7A)
ASP  A 275 ( 0.5A)
LEU  A 270 ( 0.6A)
ARG  A 247 ( 0.6A)
 1.46A 2a7qA-2nvvA:
undetectable		 2a7qA-2nvvA:
20.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2p62 HYPOTHETICAL PROTEIN
PH0156

(Pyrococcus
horikoshii) 		PF11536
(DUF3226) 		4 ILE A  39
ASP A  80
LEU A  87
ARG A  70
 None
 1.14A 2a7qA-2p62A:
3.4		 2a7qA-2p62A:
25.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2py6 METHYLTRANSFERASE
FKBM

(Methylobacillus
flagellatus) 		PF05050
(Methyltransf_21) 		4 ILE A 166
ASP A 374
LEU A 176
ARG A 168
 None
None
None
EDO  A 413 (-3.8A)
 1.35A 2a7qA-2py6A:
undetectable		 2a7qA-2py6A:
20.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2qv5 UNCHARACTERIZED
PROTEIN ATU2773

(Agrobacterium
fabrum) 		PF04748
(Polysacc_deac_2) 		4 ILE A 258
ASP A 246
LEU A 233
ARG A 299
 None
 0.98A 2a7qA-2qv5A:
undetectable		 2a7qA-2qv5A:
19.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2r47 UNCHARACTERIZED
PROTEIN MTH_862

(Methanothermobacter
thermautotrophicus) 		PF09897
(DUF2124) 		4 ILE A  27
ASP A 139
LEU A  88
ARG A  26
 None
 1.46A 2a7qA-2r47A:
undetectable		 2a7qA-2r47A:
19.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2w4g MYOSIN HEAVY CHAIN,
SKELETAL MUSCLE,
ADULT

(Gallus gallus) 		PF00063
(Myosin_head)
PF02736
(Myosin_N) 		4 ILE M 480
ASP M 463
LEU M 660
ARG M 245
 None
 1.47A 2a7qA-2w4gM:
undetectable		 2a7qA-2w4gM:
16.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2wjv REGULATOR OF
NONSENSE TRANSCRIPTS
1

(Homo sapiens) 		PF04851
(ResIII)
PF09416
(UPF1_Zn_bind)
PF13086
(AAA_11)
PF13087
(AAA_12) 		4 ILE A 565
ASP A 582
LEU A 577
ARG A 624
 None
None
None
SO4  A 999 (-2.9A)
 1.25A 2a7qA-2wjvA:
undetectable		 2a7qA-2wjvA:
16.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2yjg LACTATE RACEMASE
APOPROTEIN

(Thermoanaerobacterium
thermosaccharolyticum) 		PF09861
(DUF2088) 		4 ILE A   6
ASP A  16
LEU A 399
ARG A  27
 None
 1.19A 2a7qA-2yjgA:
undetectable		 2a7qA-2yjgA:
22.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3a2f DNA POLYMERASE

(Pyrococcus
furiosus) 		PF00136
(DNA_pol_B)
PF03104
(DNA_pol_B_exo1) 		4 ILE A 256
ASP A   6
LEU A 121
ARG A 346
 None
 1.44A 2a7qA-3a2fA:
undetectable		 2a7qA-3a2fA:
16.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3b1r RIBOKINASE, PUTATIVE

(Burkholderia
thailandensis) 		PF00294
(PfkB) 		4 ILE A 219
ASP A 201
LEU A 171
ARG A 229
 None
 1.31A 2a7qA-3b1rA:
undetectable		 2a7qA-3b1rA:
18.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3bw8 MONO-ADP-RIBOSYLTRAN
SFERASE C3

(Hathewaya
limosa) 		PF03496
(ADPrib_exo_Tox) 		4 ILE A  38
ASP A  72
LEU A 176
ARG A  45
 None
 1.25A 2a7qA-3bw8A:
undetectable		 2a7qA-3bw8A:
22.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3fhx PYRIDOXAL KINASE

(Homo sapiens) 		PF08543
(Phos_pyr_kin) 		4 ILE A  97
ASP A  60
LEU A  57
ARG A  70
 None
None
None
SO4  A 316 (-3.0A)
 1.30A 2a7qA-3fhxA:
2.4		 2a7qA-3fhxA:
21.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3hm8 HEXOKINASE-3

(Homo sapiens) 		PF00349
(Hexokinase_1)
PF03727
(Hexokinase_2) 		4 ILE A 751
ASP A 720
LEU A 519
ARG A 835
 None
 1.21A 2a7qA-3hm8A:
undetectable		 2a7qA-3hm8A:
19.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3htz ALANYL-TRNA
SYNTHETASE

(Aquifex
aeolicus) 		PF01411
(tRNA-synt_2c) 		4 ILE A 295
ASP A 271
LEU A 316
ARG A 297
 None
 1.25A 2a7qA-3htzA:
undetectable		 2a7qA-3htzA:
20.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3kzx HAD-SUPERFAMILY
HYDROLASE, SUBFAMILY
IA, VARIANT 1

(Ehrlichia
chaffeensis) 		PF13419
(HAD_2) 		4 ILE A 103
ASP A  79
LEU A  83
ARG A 113
 None
 1.33A 2a7qA-3kzxA:
undetectable		 2a7qA-3kzxA:
21.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3lif PUTATIVE DIGUANYLATE
CYCLASE (GGDEF) WITH
PAS/PAC DOMAIN

(Rhodopseudomonas
palustris) 		PF02743
(dCache_1) 		4 ILE A  81
ASP A 111
LEU A 121
ARG A  98
 None
MPD  A   1 ( 4.3A)
None
None
 1.39A 2a7qA-3lifA:
undetectable		 2a7qA-3lifA:
20.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3ob8 BETA-GALACTOSIDASE

(Kluyveromyces
lactis) 		PF00703
(Glyco_hydro_2)
PF02836
(Glyco_hydro_2_C)
PF02837
(Glyco_hydro_2_N)
PF02929
(Bgal_small_N) 		4 ILE A 474
ASP A 398
LEU A 374
ARG A 331
 None
 1.49A 2a7qA-3ob8A:
undetectable		 2a7qA-3ob8A:
12.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3q87 N6 ADENINE SPECIFIC
DNA METHYLASE

(Encephalitozoon
cuniculi) 		PF05175
(MTS) 		4 ILE B 107
ASP B  69
LEU B  30
ARG B 135
 None
SAM  B 300 (-3.7A)
None
None
 1.42A 2a7qA-3q87B:
undetectable		 2a7qA-3q87B:
21.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3t5v NUCLEAR MRNA EXPORT
PROTEIN THP1

(Saccharomyces
cerevisiae) 		PF01399
(PCI) 		4 ILE B 145
ASP B  85
LEU B  21
ARG B 151
 None
 1.39A 2a7qA-3t5vB:
undetectable		 2a7qA-3t5vB:
19.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3v5r PROTEIN GAL3

(Saccharomyces
cerevisiae) 		PF00288
(GHMP_kinases_N)
PF08544
(GHMP_kinases_C)
PF10509
(GalKase_gal_bdg) 		4 ILE A 135
ASP A 184
LEU A 190
ARG A 139
 None
None
None
SO4  A 523 (-3.8A)
 1.23A 2a7qA-3v5rA:
undetectable		 2a7qA-3v5rA:
19.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3wtc PUTATIVE
OXIDOREDUCTASE

(Gluconobacter
oxydans) 		PF00106
(adh_short) 		4 ILE A   7
ASP A  75
LEU A  35
ARG A  55
 None
 1.38A 2a7qA-3wtcA:
2.8		 2a7qA-3wtcA:
21.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4aez MITOTIC SPINDLE
CHECKPOINT COMPONENT
MAD3

(Schizosaccharomyces
pombe) 		PF08311
(Mad3_BUB1_I) 		4 ILE C 122
ASP C  84
LEU C  96
ARG C 121
 None
 1.45A 2a7qA-4aezC:
undetectable		 2a7qA-4aezC:
20.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4dvg DIAPHANOUS PROTEIN

(Entamoeba
histolytica) 		PF06367
(Drf_FH3)
PF06371
(Drf_GBD) 		4 ILE B 184
ASP B 144
LEU B 176
ARG B 234
 None
 1.21A 2a7qA-4dvgB:
undetectable		 2a7qA-4dvgB:
22.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4dxy CYTOCHROME P450

(Novosphingobium
aromaticivorans) 		PF00067
(p450) 		4 ILE A 214
ASP A 224
LEU A 251
ARG A 238
 None
None
HEM  A 501 (-4.8A)
None
 1.37A 2a7qA-4dxyA:
undetectable		 2a7qA-4dxyA:
20.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4gvl TRKA DOMAIN PROTEIN

(Geobacter
sulfurreducens) 		PF02080
(TrkA_C)
PF02254
(TrkA_N) 		4 ILE A 546
ASP A 558
LEU A 510
ARG A 544
 None
 1.37A 2a7qA-4gvlA:
undetectable		 2a7qA-4gvlA:
20.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4hh1 APPA PROTEIN

(Rhodobacter
sphaeroides) 		PF04940
(BLUF) 		4 ILE A  79
ASP A  36
LEU A  29
ARG A  81
 FMN  A 500 (-4.1A)
None
None
None
 1.28A 2a7qA-4hh1A:
undetectable		 2a7qA-4hh1A:
20.66
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4hhr ALPHA-DIOXYGENASE

(Arabidopsis
thaliana) 		PF03098
(An_peroxidase) 		4 ILE A 507
ASP A 535
LEU A 540
ARG A 500
 P6G  A 715 (-4.8A)
None
None
None
 1.26A 2a7qA-4hhrA:
undetectable		 2a7qA-4hhrA:
18.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4hv6 TRANSCRIPTIONAL
REGULATOR MNTR

(Bacillus
subtilis) 		PF01325
(Fe_dep_repress)
PF02742
(Fe_dep_repr_C) 		4 ILE A  28
ASP A  47
LEU A  62
ARG A  24
 None
 1.47A 2a7qA-4hv6A:
undetectable		 2a7qA-4hv6A:
22.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4im4 ENDOGLUCANASE E

(Ruminiclostridium
thermocellum) 		PF00150
(Cellulase) 		4 ILE A 155
ASP A 110
LEU A 147
ARG A 163
 None
 1.40A 2a7qA-4im4A:
undetectable		 2a7qA-4im4A:
21.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4kvl FATTY ACID
ALPHA-OXIDASE

(Oryza sativa) 		PF03098
(An_peroxidase) 		4 ILE A 500
ASP A 528
LEU A 533
ARG A 493
 1PE  A 707 (-4.8A)
None
None
None
 1.29A 2a7qA-4kvlA:
undetectable		 2a7qA-4kvlA:
16.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4p3z COPN

(Chlamydia
pneumoniae) 		PF07201
(HrpJ) 		4 ILE A 185
ASP A 147
LEU A 141
ARG A 177
 None
 1.36A 2a7qA-4p3zA:
undetectable		 2a7qA-4p3zA:
22.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4p7c TRNA
(MO5U34)-METHYLTRANS
FERASE

(Pseudomonas
syringae group
genomosp. 3) 		PF08003
(Methyltransf_9) 		4 ILE A 202
ASP A 210
LEU A 218
ARG A 260
 None
 1.40A 2a7qA-4p7cA:
undetectable		 2a7qA-4p7cA:
21.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5b04 PROBABLE TRANSLATION
INITIATION FACTOR
EIF-2B SUBUNIT BETA
PROBABLE TRANSLATION
INITIATION FACTOR
EIF-2B SUBUNIT DELTA

(Schizosaccharomyces
pombe) 		PF01008
(IF-2B) 		4 ILE C 336
ASP C 261
LEU G 329
ARG G 308
 None
 1.34A 2a7qA-5b04C:
undetectable		 2a7qA-5b04C:
19.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5frs SISTER CHROMATID
COHESION PROTEIN
PDS5

(Saccharomyces
cerevisiae) 		PF12717
(Cnd1) 		4 ILE A 306
ASP A 321
LEU A 288
ARG A 352
 None
 1.21A 2a7qA-5frsA:
undetectable		 2a7qA-5frsA:
16.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5gje LOW-DENSITY
LIPOPROTEIN
RECEPTOR-RELATED
PROTEIN 6

(Homo sapiens) 		PF00058
(Ldl_recept_b)
PF14670
(FXa_inhibition) 		4 ILE A 333
ASP A 371
LEU A 311
ARG A 316
 None
 1.25A 2a7qA-5gjeA:
undetectable		 2a7qA-5gjeA:
18.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5gx8 EXTRACELLULAR
SOLUTE-BINDING
PROTEIN FAMILY 1

(Streptobacillus
moniliformis) 		PF13416
(SBP_bac_8) 		4 ILE A 285
ASP A 427
LEU A 308
ARG A 322
 None
EDO  A 602 ( 4.7A)
None
None
 1.38A 2a7qA-5gx8A:
undetectable		 2a7qA-5gx8A:
19.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5l6s GLUCOSE-1-PHOSPHATE
ADENYLYLTRANSFERASE

(Escherichia
coli) 		PF00483
(NTP_transferase) 		4 ILE A 414
ASP A 363
LEU A 367
ARG A 409
 None
 1.23A 2a7qA-5l6sA:
undetectable		 2a7qA-5l6sA:
19.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5m5x DNA-DIRECTED RNA
POLYMERASE I SUBUNIT
RPA135

(Saccharomyces
cerevisiae) 		PF00562
(RNA_pol_Rpb2_6)
PF04560
(RNA_pol_Rpb2_7)
PF04561
(RNA_pol_Rpb2_2)
PF04563
(RNA_pol_Rpb2_1)
PF04565
(RNA_pol_Rpb2_3)
PF06883
(RNA_pol_Rpa2_4) 		4 ILE B 907
ASP B 738
LEU B 733
ARG B 909
 None
 1.22A 2a7qA-5m5xB:
undetectable		 2a7qA-5m5xB:
11.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5mc5 XAA-PRO DIPEPTIDASE

(Homo sapiens) 		no annotation 4 ILE A 346
ASP A 419
LEU A 426
ARG A 442
 None
 1.45A 2a7qA-5mc5A:
undetectable		 2a7qA-5mc5A:
14.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5o84 GLUTATHIONE
S-TRANSFERASE U23

(Arabidopsis
thaliana) 		no annotation 4 ILE A  68
ASP A 154
LEU A 135
ARG A  96
 None
 1.46A 2a7qA-5o84A:
undetectable		 2a7qA-5o84A:
20.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5tuc SUS TBC1D15 GAP
DOMAIN

(Sus scrofa) 		PF00566
(RabGAP-TBC) 		4 ILE A 528
ASP A 582
LEU A 548
ARG A 335
 None
 1.33A 2a7qA-5tucA:
undetectable		 2a7qA-5tucA:
21.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5u30 CRISPR-ASSOCIATED
ENDONUCLEASE C2C1

(Alicyclobacillus
acidoterrestris) 		no annotation 4 ILE A 579
ASP A 814
LEU A 622
ARG A 616
 None
C  B  91 ( 3.4A)
None
G  B   8 ( 4.8A)
 1.45A 2a7qA-5u30A:
undetectable		 2a7qA-5u30A:
13.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5uak CYSTIC FIBROSIS
TRANSMEMBRANE
CONDUCTANCE
REGULATOR

(Homo sapiens) 		PF00005
(ABC_tran)
PF00664
(ABC_membrane)
PF14396
(CFTR_R) 		4 ILE A1103
ASP A1152
LEU A1034
ARG A1097
 None
 1.47A 2a7qA-5uakA:
undetectable		 2a7qA-5uakA:
10.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5xbp 3NT OXYGENASE ALPHA
SUBUNIT
3NT OXYGENASE BETA
SUBUNIT

(Diaphorobacter
sp. DS2) 		PF00355
(Rieske)
PF00848
(Ring_hydroxyl_A)
PF00866
(Ring_hydroxyl_B) 		4 ILE A 214
ASP A 362
LEU C 189
ARG A 216
 None
 1.48A 2a7qA-5xbpA:
undetectable		 2a7qA-5xbpA:
17.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5xgz BETA-GLYCOSIDASE

(uncultured
microorganism) 		no annotation 4 ILE A 432
ASP A  68
LEU A  75
ARG A 418
 None
 1.04A 2a7qA-5xgzA:
1.1		 2a7qA-5xgzA:
14.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5y7i CHLORIDE
INTRACELLULAR
CHANNEL PROTEIN 2

(Oreochromis
mossambicus) 		no annotation 4 ILE A 116
ASP A 181
LEU A 214
ARG A 143
 None
 1.07A 2a7qA-5y7iA:
undetectable		 2a7qA-5y7iA:
12.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5y7o UGGT

(Thermomyces
dupontii) 		PF06427
(UDP-g_GGTase) 		4 ILE A  89
ASP A  75
LEU A  46
ARG A  67
 None
 1.26A 2a7qA-5y7oA:
undetectable		 2a7qA-5y7oA:
12.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6c8z ADP-DEPENDENT
PHOSPHOFRUCTOKINASE

(Methanosarcinales) 		no annotation 4 ILE A  38
ASP A  45
LEU A 102
ARG A 206
 None
NI  A 504 (-2.5A)
None
None
 1.34A 2a7qA-6c8zA:
2.3		 2a7qA-6c8zA:
14.89